Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Trading Down 2.4% – Here’s Why

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) shares fell 2.4% on Thursday . The company traded as low as $39.32 and last traded at $39.32. 2,233 shares were traded during trading, a decline of 67% from the average session volume of 6,861 shares. The stock had previously closed at $40.30.

Innovator IBD Breakout Opportunities ETF Stock Performance

The firm has a market cap of $13.76 million, a P/E ratio of 28.69 and a beta of 1.08. The company has a 50 day moving average of $39.59 and a 200 day moving average of $38.40.

Innovator IBD Breakout Opportunities ETF Announces Dividend

The firm also recently announced an annual dividend, which was paid on Friday, January 2nd. Shareholders of record on Wednesday, December 31st were paid a $0.1249 dividend. The ex-dividend date was Wednesday, December 31st. This represents a yield of 34.0%.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of BOUT. Comprehensive Wealth Management LLC raised its holdings in shares of Innovator IBD Breakout Opportunities ETF by 122.0% during the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after purchasing an additional 12,859 shares in the last quarter. Susquehanna International Group LLP boosted its holdings in Innovator IBD Breakout Opportunities ETF by 42.6% in the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after purchasing an additional 7,817 shares in the last quarter. Finally, Osaic Holdings Inc. boosted its holdings in Innovator IBD Breakout Opportunities ETF by 39.7% in the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after purchasing an additional 597 shares in the last quarter.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.